Who owns Navidea Biopharmaceuticals Inc?
- Ticker: NAVB
- CUSIP Number: 63937x202
Tip: Access positions for across all investors
Analyze quarterly positions in Navidea Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Navidea Biopharmaceuticals stock
Who bought or sold Navidea Biopharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Parallel Advisors | 350.00 | $12.985000 | 0% | Mar 2024 |
|
| Beacon Capital Management | 10.00 | $1.000000 | 0% | Dec 2023 |
|
Who sold out of Navidea Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2023 | 333k | $30k |
| Vanguard Group | Sep 2023 | 277k | $25k |
| UBS Group | Sep 2023 | 150k | $14k |
| Level Four Advisory Services | Sep 2023 | 56k | $5.0k |
| Two Sigma Securities | Sep 2023 | 32k | $2.8k |
| Baader Bank | Dec 2023 | 11k | $434.767000 |
| Wells Fargo & Company | Sep 2023 | 5.6k | $375.654400 |
| Bank of America Corporation | Sep 2023 | 1.6k | $143.076800 |
| Jpmorgan Chase & Co | Sep 2023 | 1.3k | $114.400000 |
| Advisory Services Network | Dec 2023 | 250.00 | $14.000000 |